PKO Investment Management Joint-Stock’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Hold |
6,000
| – | – | 0.02% | 173 |
|
|
2025
Q1 | $170K | Hold |
6,000
| – | – | 0.02% | 173 |
|
|
2024
Q4 | $249K | Hold |
6,000
| – | – | 0.03% | 153 |
|
|
2024
Q3 | $401K | Buy |
6,000
+4,300
| +253% | +$287K | 0.05% | 144 |
|
|
2024
Q2 | $202K | Sell |
1,700
-1,800
| -51% | -$214K | 0.02% | 162 |
|
|
2024
Q1 | $375K | Sell |
3,500
-23,500
| -87% | -$2.52M | 0.04% | 148 |
|
|
2023
Q4 | $2.69M | Sell |
27,000
-14,000
| -34% | -$1.39M | 0.34% | 53 |
|
|
2023
Q3 | $4.23M | Sell |
41,000
-2,305
| -5% | -$238K | 0.57% | 29 |
|
|
2023
Q2 | $5.26M | Buy |
43,305
+35,605
| +462% | +$4.33M | 0.64% | 27 |
|
|
2023
Q1 | $1.18M | Buy |
7,700
+6,200
| +413% | +$952K | 0.16% | 102 |
|
|
2022
Q4 | $269K | Sell |
1,500
-1,500
| -50% | -$269K | 0.04% | 129 |
|
|
2022
Q3 | $355K | Sell |
3,000
-171
| -5% | -$20.2K | 0.06% | 122 |
|
|
2022
Q2 | $453K | Hold |
3,171
| – | – | 0.07% | 112 |
|
|
2022
Q1 | $546K | Hold |
3,171
| – | – | 0.07% | 105 |
|
|
2021
Q4 | $805K | Buy |
+3,171
| New | +$805K | 0.09% | 99 |
|